Advertisement

Topics

First Look at New CDK 4/6 Data in Metastatic Breast Cancer

13:02 EDT 5 Jun 2017 | Medscape

ASCO 2017 featured a number of important studies looking at the role of CDK 4/6 inhibitors in patients with hormone receptor-positive, HER2-negative metastatic breast cancer.
Medscape Oncology

Original Article: First Look at New CDK 4/6 Data in Metastatic Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "First Look at New CDK 4/6 Data in Metastatic Breast Cancer"

Quick Search
Advertisement
 

Relevant Topic

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...